From Anti-Parkinson's Drug Rasagiline to Novel Multitarget Iron Chelators with Acetylcholinesterase and Monoamine Oxidase Inhibitory and Neuroprotective Properties for Alzheimer's Disease-Reference-Cited by-同舟云学术

From Anti-Parkinson's Drug Rasagiline to Novel Multitarget Iron Chelators with Acetylcholinesterase and Monoamine Oxidase Inhibitory and Neuroprotective Properties for Alzheimer's Disease

Published:2012-05-04 Issue:1 Volume:30 Page:1-16
ISSN:1875-8908
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Zheng Hailin¹,Amit Tamar²,Bar-Am Orit²,Fridkin Mati³,Youdim Moussa B.H.²⁴,Mandel Silvia A.²

Affiliation:

1. Department of Medicinal Chemistry, Intra-Cellular Therapies Inc., New York, NY, USA

2. Eve Topf Center of Excellence for Neurodegenerative Diseases and Department of Pharmacology, Technion-Rappaport Family Faculty of Medicine Haifa, Israel

3. Department of Organic Chemistry, The Weizmann Institute of Science, Rehovot, Israel

4. Department of Biology, Yonsei World Central University, Seoul, South Korea

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel AP2238-clorgiline hybrids as multi-target agents for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation;Bioorganic Chemistry;2023-01

2. Combinatory Approaches Targeting Cognitive Impairments and Memory Enhancement: A Review;Current Drug Targets;2023-01

3. Protective Mechanisms of Nootropic Herb Shankhpushpi (Convolvulus pluricaulis) against Dementia: Network Pharmacology and Computational Approach;Evidence-Based Complementary and Alternative Medicine;2022-10-03

4. Discovery of novel neuroprotective cinnamoyl-M30D hybrids targeting Alzheimer’s disease;Medicinal Chemistry Research;2022-09-10

5. Supportive Pharmacological Treatment;Pharmacological Treatment of Alzheimer's Disease;2022